Calculator topics: Difference between revisions

Jump to navigation Jump to search
 
(32 intermediate revisions by 2 users not shown)
Line 4: Line 4:


{{CMG}}; {{AE}} {{SSH}}
{{CMG}}; {{AE}} {{SSH}}
<div class="mw-collapsible">
<div class="mw-collapsible mw-collapsed">
==CARDIOLOGY==
==CARDIOLOGY==
<div class="mw-collapsible-content">
<div class="mw-collapsible-content">
Line 12: Line 12:
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Topic
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Topic
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Calculators
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Calculators
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Author
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Purpose
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Reviewer
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Type
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Status
|-
|-
! align="center" style="background:#DCDCDC;" + |Atrial fibrilation
! align="center" style="background:#DCDCDC;" + |Coronary artery disease
| align="left" style="background:#F5F5F5;" + |[[HAS-BLED score]]
| align="left" style="background:#F5F5F5;" + |[[ACTION ICU risk score]]
| align="left" style="background:#F5F5F5;" + |[[User:Ssharfaei|Sadaf Sharfaei]]
| align="left" style="background:#F5F5F5;" + |Predicts need for ICU care in stable adults with [[Unstable angina / non ST elevation myocardial infarction|NSTEMI]]
| align="left" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Score
| align="left" style="background:#F5F5F5;" + |Completed
|-
! align="center" style="background:#DCDCDC;" + |MACE
| align="left" style="background:#F5F5F5;" + |ADAPT Protocol for Cardiac Event Risk
| align="left" style="background:#F5F5F5;" + |Assesses chest pain patients at 2 hours for risk of cardiac event
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |DVT
| align="left" style="background:#F5F5F5;" + |[[AMUSE score]]
| align="left" style="background:#F5F5F5;" + |Evaluates the need to proceed with ultrasonography among patients with suspected DVT
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |Anticoagulation
| align="left" style="background:#F5F5F5;" + |ATRIA bleeding risk score
| align="left" style="background:#F5F5F5;" + |Determines bleeding risk for patients on warfarin
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |Arrythmia
| align="left" style="background:#F5F5F5;" + |ATRIA stroke risk score
| align="left" style="background:#F5F5F5;" + |Determines stroke risk in patients with atrial fibrillation
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |Arrythmia/Stroke
| align="left" style="background:#F5F5F5;" + |Atrial fibrillation 5-year risk of stroke (Framingham Heart Study)
| align="left" style="background:#F5F5F5;" + |Predicts 5-year risk of stroke in patients with atrial fibrillation
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |Arrythmia/Stroke
| align="left" style="background:#F5F5F5;" + |Atrial fibrillation 5-year risk of stroke or death (Framingham Heart Study)
| align="left" style="background:#F5F5F5;" + |Predicts 5-year risk of stroke or death in patients with atrial fibrillation
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |Alcoholism
| align="left" style="background:#F5F5F5;" + |CAGE questions
| align="left" style="background:#F5F5F5;" + |Screens for excessive drinking and alcoholism
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |Syncope
| align="left" style="background:#F5F5F5;" + |Canadian syncope risk score
| align="left" style="background:#F5F5F5;" + |Predicts 30-day serious adverse events in patients presenting with syncope
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |VTE
| align="left" style="background:#F5F5F5;" + |[[Caprini score]]
| align="left" style="background:#F5F5F5;" + |Stratifies risk of VTE in surgical patients
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |MACE
| align="left" style="background:#F5F5F5;" + |Cardiac Risk Index for AAA Surgery (Lee)
| align="left" style="background:#F5F5F5;" + |Calculates the approximate risk of cardiac complication after AAA surgery
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |MACE
| align="left" style="background:#F5F5F5;" + |Cardiac Risk Index for Abdominal Surgery (Lee)
| align="left" style="background:#F5F5F5;" + |Calculates the approximate risk of cardiac complication after abdominal surgery
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |MACE
| align="left" style="background:#F5F5F5;" + |Cardiac Risk Index for Pre-Operative Risk, revised
| align="left" style="background:#F5F5F5;" + |Estimates risk of cardiac complications after noncardiac surgery
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |MACE
| align="left" style="background:#F5F5F5;" + |Cardiovascular Risk Assessment (10-year, PROCAM Score, Munster Heart Study)
| align="left" style="background:#F5F5F5;" + |Predicts 10-year cardiovascular risk based on risk factors like history of MI, diabetes or high cholesterol
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |Cardiac arrest
| align="left" style="background:#F5F5F5;" + |CART (Cardiac Arrest Risk Triage) Score
| align="left" style="background:#F5F5F5;" + |Predicts risk of in-hospital cardiac arrest
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |Arrythmia/Stroke
| align="left" style="background:#F5F5F5;" + |[[CHA2DS2-VASc Score|CHA₂DS₂-VASc Score for Atrial Fibrillation Stroke Risk]]
| align="left" style="background:#F5F5F5;" + |Calculates stroke risk for patients with atrial fibrillation, possibly better than the CHADS₂ Score
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |Arrythmia/Stroke
| align="left" style="background:#F5F5F5;" + |[[CHADS2 score|CHADS₂ Score for Atrial Fibrillation Stroke Risk]]
| align="left" style="background:#F5F5F5;" + |Estimates stroke risk in patients with atrial fibrillation
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |Survival
| align="left" style="background:#F5F5F5;" + |Charlson Comorbidity Index (CCI)
| align="left" style="background:#F5F5F5;" + |Predicts 10-year survival in patients with multiple comorbidities
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |Stroke
| align="left" style="background:#F5F5F5;" + |[[Cincinnati stroke scale|Cincinnati Prehospital Stroke Severity Scale (CP-SSS)]]
| align="left" style="background:#F5F5F5;" + |Predicts large vessel occlusion (LVO) and severe stroke in patients with stroke symptoms
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |Coronary artery disease/Bleeding
| align="left" style="background:#F5F5F5;" + |CRUSADE Score for Post-MI Bleeding Risk
| align="left" style="background:#F5F5F5;" + |Stratifies bleeding risk after NSTEMI
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |VTE
| align="left" style="background:#F5F5F5;" + |[[DASH prediction score]]
| align="left" style="background:#F5F5F5;" + |Predicts disease recurrence in patients with prior unprovoked [[Venous thromboembolism|VTE]]
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |Coronary artery disease
| align="left" style="background:#F5F5F5;" + |[[DAPT score]]
| align="left" style="background:#F5F5F5;" + |Predicts which patients will benefit from prolonged [[dual antiplatelet therapy]] after coronary stent placement
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |Syncope
| align="left" style="background:#F5F5F5;" + |EGSYS (Evaluation of Guidelines in SYncope Study) Score for Syncope
| align="left" style="background:#F5F5F5;" + |Predicts likelihood that syncope is from cardiac cause
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |VTE
| align="left" style="background:#F5F5F5;" + |Geneva Risk Score for Venous Thromboembolism (VTE) Prophylaxis
| align="left" style="background:#F5F5F5;" + |Predicts need for VTE prophylaxis in admitted patients
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |PE
| align="left" style="background:#F5F5F5;" + |[[Geneva score calculator|Geneva score for PE, original]]
| align="left" style="background:#F5F5F5;" + |Determines the pre-test probability of PE based on a patient's risk factors and clinical findings
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |PE
| align="left" style="background:#F5F5F5;" + |[[Revised Geneva score calculator|Geneva score for PE, revised]]
| align="left" style="background:#F5F5F5;" + |Objectifies risk of PE, like Wells’ score
| align="center" style="background:#F5F5F5;" + |Score
|-
|-
! align="center" style="background:#DCDCDC;" + |Atrial fibrilation
! align="center" style="background:#DCDCDC;" + |PE
| align="left" style="background:#F5F5F5;" + |[[CHA2DS2-VASc Score]]
| align="left" style="background:#F5F5F5;" + |[[Simplified Geneva Score calculator|Geneva score for PE, simplified]]
| align="left" style="background:#F5F5F5;" + |[[User:Ssharfaei|Sadaf Sharfaei]]
| align="left" style="background:#F5F5F5;" + |Determines the pre-test probability of PE based on a patient's risk factors and clinical findings
| align="left" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Score
| align="left" style="background:#F5F5F5;" + |Completed
|-
|-
! align="center" style="background:#DCDCDC;" + |Atrial fibrilation
! align="center" style="background:#DCDCDC;" + |Cardiac arrest/Survival
| align="left" style="background:#F5F5F5;" + |[[CHADS2 score]]
| align="left" style="background:#F5F5F5;" + |GO-FAR (Good Outcome Following Attempted Resuscitation) Score
| align="left" style="background:#F5F5F5;" + |[[User:Ssharfaei|Sadaf Sharfaei]]
| align="left" style="background:#F5F5F5;" + |Predicts survival to discharge with good outcome after in-hospital cardiac arrest
| align="left" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Score
| align="left" style="background:#F5F5F5;" + |Completed
|-
|-
! align="center" style="background:#DCDCDC;" + |Coronary artery disease
! align="center" style="background:#DCDCDC;" + |Coronary artery disease
| align="left" style="background:#F5F5F5;" + |[[TIMI Risk Score for STEMI]]
| align="left" style="background:#F5F5F5;" + |[[The GRACE risk score|Grace Risk Score for All-Cause Mortality From Discharge to 6 Months]]
| align="left" style="background:#F5F5F5;" + |[[User:Ssharfaei|Sadaf Sharfaei]]
| align="left" style="background:#F5F5F5;" + |Assesses the risk of 6-month mortality among patients with acute coronary syndrome
| align="left" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Score
| align="left" style="background:#F5F5F5;" + |Completed
|-
|-
! align="center" style="background:#DCDCDC;" + |Coronary artery disease
! align="center" style="background:#DCDCDC;" + |Coronary artery disease
| align="left" style="background:#F5F5F5;" + |[[TIMI Risk Score for Unstable Angina or NSTEMI]]
| align="left" style="background:#F5F5F5;" + |[[The GRACE risk score|Grace Risk Score for In-Hospital Mortality]]
| align="left" style="background:#F5F5F5;" + |[[User:Ssharfaei|Sadaf Sharfaei]]
| align="left" style="background:#F5F5F5;" + |Assesses the risk of in-hospital mortality among patients with acute coronary syndrome
| align="left" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Score
| align="left" style="background:#F5F5F5;" + |Completed
|-
|-
! align="center" style="background:#DCDCDC;" + |DVT
! align="center" style="background:#DCDCDC;" + |DVT
| align="left" style="background:#F5F5F5;" + |[[AMUSE score calculator]]
| align="left" style="background:#F5F5F5;" + |[[HAMILTON score calculator|HAMILTON score]]
| align="left" style="background:#F5F5F5;" + |[[User:Ssharfaei|Sadaf Sharfaei]]
| align="left" style="background:#F5F5F5;" + |Assesses the pretest probability of DVT among ambulatory outpatients
| align="left" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Score
| align="left" style="background:#F5F5F5;" + |Completed
|-
! align="center" style="background:#DCDCDC;" + |Bleeding
| align="left" style="background:#F5F5F5;" + |[[HAS-BLED score|HAS-BLED Score for Major Bleeding Risk]]
| align="left" style="background:#F5F5F5;" + |Estimates risk of major bleeding for patients on anticoagulation to assess risk-benefit in atrial fibrillation care
| align="center" style="background:#F5F5F5;" + |Score
|-
|-
! align="center" style="background:#DCDCDC;" + |DVT
! align="center" style="background:#DCDCDC;" + |Coronary artery disease
| align="left" style="background:#F5F5F5;" + |[[HAMILTON score calculator]]
| align="left" style="background:#F5F5F5;" + |HEART Pathway for Early Discharge in Acute Chest Pain
| align="left" style="background:#F5F5F5;" + |[[User:Ssharfaei|Sadaf Sharfaei]]
| align="left" style="background:#F5F5F5;" + |Identifies emergency department patients with acute chest pain for early discharge
| align="left" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Score
| align="left" style="background:#F5F5F5;" + |Completed
|-
|-
! align="center" style="background:#DCDCDC;" + |DVT
! align="center" style="background:#DCDCDC;" + |MACE
| align="left" style="background:#F5F5F5;" + |[[Modified Wells score calculator for DVT]]
| align="left" style="background:#F5F5F5;" + |HEART Score for Major Cardiac Events
| align="left" style="background:#F5F5F5;" + |[[User:Ssharfaei|Sadaf Sharfaei]]
| align="left" style="background:#F5F5F5;" + |Predicts 6-week risk of major adverse cardiac event
| align="left" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Score
| align="left" style="background:#F5F5F5;" + |Completed
|-
|-
! align="center" style="background:#DCDCDC;" + |DVT
! align="center" style="background:#DCDCDC;" + |Arrythmia/Bleeding
| align="left" style="background:#F5F5F5;" + |[[Wells score calculator for DVT]]
| align="left" style="background:#F5F5F5;" + |HEMORR₂HAGES Score for Major Bleeding Risk
| align="left" style="background:#F5F5F5;" + |[[User:Ssharfaei|Sadaf Sharfaei]]
| align="left" style="background:#F5F5F5;" + |Quantifies risk of hemorrhage in elderly patients with AFib
| align="left" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Score
| align="left" style="background:#F5F5F5;" + |Completed
|-
|-
! align="center" style="background:#DCDCDC;" + |PE
! align="center" style="background:#DCDCDC;" + |PE
| align="left" style="background:#F5F5F5;" + |[[Pulmonary embolism Wells score calculator]]
| align="left" style="background:#F5F5F5;" + |Hestia Criteria for Outpatient Pulmonary Embolism Treatment
| align="left" style="background:#F5F5F5;" + |[[User:Ssharfaei|Sadaf Sharfaei]]
| align="left" style="background:#F5F5F5;" + |Identifies low-risk PE patients safe for outpatient treatment
| align="left" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Score
| align="left" style="background:#F5F5F5;" + |Completed
|-
! align="center" style="background:#DCDCDC;" + |Bleeding
| align="left" style="background:#F5F5F5;" + |[[IMPROVE bleeding risk score]]
| align="left" style="background:#F5F5F5;" + |Estimates the probability of major or clinically important in-hospital bleeding from the time of hospital admission up to 14 days following admission
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |VTE
| align="left" style="background:#F5F5F5;" + |[[IMPROVE VTE risk score]]
| align="left" style="background:#F5F5F5;" + |Estimates the probability of clinically evident acute venous thromboembolism from the time of hospital admission to discharge
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |VTE
| align="left" style="background:#F5F5F5;" + |[[IMPROVEDD VTE risk score]]
| align="left" style="background:#F5F5F5;" + |Estimates the probability of venous thromboembolism from the time of hospital admission up to 77 days
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |Infective endocarditis/Mortality
| align="left" style="background:#F5F5F5;" + |Infective Endocarditis (IE) Mortality Risk Score
| align="left" style="background:#F5F5F5;" + |Predicts mortality at 6 months in patients with infective endocarditis
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |Coronary artery disease
| align="left" style="background:#F5F5F5;" + |Marburg Heart Score (MHS)
| align="left" style="background:#F5F5F5;" + |Rules out coronary artery disease in primary care patients with chest pain
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |Nephropathy
| align="left" style="background:#F5F5F5;" + |Mehran Score for Post-PCI Contrast Nephropathy
| align="left" style="background:#F5F5F5;" + |Predicts risk of contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI)
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |Syncope/Mortality
| align="left" style="background:#F5F5F5;" + |OESIL Score for Syncope
| align="left" style="background:#F5F5F5;" + |Estimates 12-month all-cause mortality in patients presenting with syncope
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |Heart failure
| align="left" style="background:#F5F5F5;" + |Ottawa Heart Failure Risk Scale (OHFRS)
| align="left" style="background:#F5F5F5;" + |Identifies ED patients with heart failure at high risk for serious adverse events
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |VTE
| align="left" style="background:#F5F5F5;" + |[[Padua prediction score|Padua Prediction Score for Risk of VTE]]
| align="left" style="background:#F5F5F5;" + |Determines anticoagulation need in hospitalized patients by risk of VTE
| align="center" style="background:#F5F5F5;" + |Score
|-
|-
! align="center" style="background:#DCDCDC;" + |PE
! align="center" style="background:#DCDCDC;" + |PE
| align="left" style="background:#F5F5F5;" + |[[Pulmonary embolism modified Wells score calculator]]
| align="left" style="background:#F5F5F5;" + |PESI (Pulmonary Embolism Severity Index)
| align="left" style="background:#F5F5F5;" + |[[User:Ssharfaei|Sadaf Sharfaei]]
| align="left" style="background:#F5F5F5;" + |Predicts 30-day outcome of patients with pulmonary embolism using 11 clinical criteria
| align="left" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Score
| align="left" style="background:#F5F5F5;" + |Completed
|-
|-
! align="center" style="background:#DCDCDC;" + |PE
! align="center" style="background:#DCDCDC;" + |PE
| align="left" style="background:#F5F5F5;" + |[[Geneva score calculator]]
| align="left" style="background:#F5F5F5;" + |PESI (Pulmonary Embolism Severity Index), simplified
| align="left" style="background:#F5F5F5;" + |[[User:Ssharfaei|Sadaf Sharfaei]]
| align="left" style="background:#F5F5F5;" + |Predicts 30-day outcome of patients with PE, with fewer criteria than the original PESI
| align="left" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Score
| align="left" style="background:#F5F5F5;" + |Completed
|-
! align="center" style="background:#DCDCDC;" + |PE/Bleeding
| align="left" style="background:#F5F5F5;" + |RIETE Score for Risk of Hemorrhage in Pulmonary Embolism Treatment
| align="left" style="background:#F5F5F5;" + |Determine the risk of major bleeding during anticoagulant therapy
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |Stroke/Mortality
| align="left" style="background:#F5F5F5;" + |SOAR Score for Stroke, modified
| align="left" style="background:#F5F5F5;" + |Predicts short-term mortality in acute ischemic stroke
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |Coronary artery disease
| align="left" style="background:#F5F5F5;" + |[[TIMI Risk Score for STEMI]]
| align="left" style="background:#F5F5F5;" + |Estimates mortality in patients with STEMI
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |Coronary artery disease
| align="left" style="background:#F5F5F5;" + |[[TIMI Risk Score for Unstable Angina or NSTEMI|TIMI Risk Score for UA/NSTEMI]]
| align="left" style="background:#F5F5F5;" + |Estimates mortality for patients with unstable angina and non-ST elevation MI
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |DVT
| align="left" style="background:#F5F5F5;" + |[[Wells score for DVT (original)]]
| align="left" style="background:#F5F5F5;" + |Estimates the pre-test probability of DVT
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |DVT
| align="left" style="background:#F5F5F5;" + |[[Wells score for DVT (modified)]]
| align="left" style="background:#F5F5F5;" + |Estimates the pre-test probability of DVT
| align="center" style="background:#F5F5F5;" + |Score
|-
|-
! align="center" style="background:#DCDCDC;" + |PE
! align="center" style="background:#DCDCDC;" + |PE
| align="left" style="background:#F5F5F5;" + |[[Simplified Geneva Score calculator]]
| align="left" style="background:#F5F5F5;" + |[[Wells score for PE (original)]]
| align="left" style="background:#F5F5F5;" + |[[User:Ssharfaei|Sadaf Sharfaei]]
| align="left" style="background:#F5F5F5;" + |Estimates the pre-test probability of PE
| align="left" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Score
| align="left" style="background:#F5F5F5;" + |Completed
|-
|-
! align="center" style="background:#DCDCDC;" + |PE
! align="center" style="background:#DCDCDC;" + |PE
| align="left" style="background:#F5F5F5;" + |[[Revised Geneva score calculator]]
| align="left" style="background:#F5F5F5;" + |[[Wells score for PE (modified)]]
| align="left" style="background:#F5F5F5;" + |[[User:Ssharfaei|Sadaf Sharfaei]]
| align="left" style="background:#F5F5F5;" + |Estimates the pre-test probability of PE
| align="left" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Score
| align="left" style="background:#F5F5F5;" + |Completed
|-
! align="center" style="background:#DCDCDC;" + |Anesthesia
| align="left" style="background:#F5F5F5;" + |Cardiac Anesthesia Risk Evaluation Score (CARE)
| align="left" style="background:#F5F5F5;" + |Predicts mortality and morbidity after cardiac surgery
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |Duke Activity Status Index (DASI)
| align="left" style="background:#F5F5F5;" + |Estimates functional capacity
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |Ehlers-Danlos Syndrome
| align="left" style="background:#F5F5F5;" + |Ehlers-Danlos Syndrome IV (vascular type) Diagnostic Criteria
| align="left" style="background:#F5F5F5;" + |Diagnoses Ehlers-Danlos Syndrome IV (vascular type)
| align="center" style="background:#F5F5F5;" + |Criteria
|-
! align="center" style="background:#DCDCDC;" + |Coronary artery disease
| align="left" style="background:#F5F5F5;" + |Emergency Department Assessment of Chest Pain Score (EDACS)
| align="left" style="background:#F5F5F5;" + |Identifies chest pain patients with low risk of major adverse cardiac event
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |MACE
| align="left" style="background:#F5F5F5;" + |EuroSCORE for Cardiac Surgery Risk Assessment
| align="left" style="background:#F5F5F5;" + |Estimates the mortality among cardiac surgical adult patients
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |MACE
| align="left" style="background:#F5F5F5;" + |Framingham 10 Year Coronary Risk Prediction by LDL (1998 paper)
| align="left" style="background:#F5F5F5;" + |Predicts 10-year risk of coronary heart disease
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |MACE
| align="left" style="background:#F5F5F5;" + |Framingham 10 Year Coronary Risk Prediction by Total Cholesterol (1998 paper)
| align="left" style="background:#F5F5F5;" + |Predicts 10-year risk of coronary heart disease
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |MACE
| align="left" style="background:#F5F5F5;" + |Framingham 10 Year Risk of General Cardiovascular Disease (2008 paper)
| align="left" style="background:#F5F5F5;" + |Predicts 10-year risk of heart disease
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |Heart failure
| align="left" style="background:#F5F5F5;" + |Framingham Heart Failure Diagnostic Criteria
| align="left" style="background:#F5F5F5;" + |Diagnoses heart failure based on major and minor criteria
| align="center" style="background:#F5F5F5;" + |Criteria
|-
! align="center" style="background:#DCDCDC;" + |Heart failure
| align="left" style="background:#F5F5F5;" + |GWTG-Heart Failure Risk Score
| align="left" style="background:#F5F5F5;" + |Predicts in-hospital all-cause heart failure mortality
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |Takayasu arteritis
| align="left" style="background:#F5F5F5;" + |Indian Takayasu Clinical Activity Score (ITAS2010)
| align="left" style="background:#F5F5F5;" + |Differentiates between active and inactive disease in Takayasu arteritis (TA)
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |Bleeding
| align="left" style="background:#F5F5F5;" + |Intracranial Bleeding Risk from Thrombolytic Therapy of MI
| align="left" style="background:#F5F5F5;" + |Estimates the risk of intracranial hemorrhage associated with thrombolytic therapy among MI patients
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |Acute Rheumatic Fever
| align="left" style="background:#F5F5F5;" + |Jones Criteria for Acute Rheumatic Fever Diagnosis
| align="left" style="background:#F5F5F5;" + |Diagnoses acute rheumatic fever based on major and minor criteria
| align="center" style="background:#F5F5F5;" + |Criteria
|-
! align="center" style="background:#DCDCDC;" + |Kawasaki Disease
| align="left" style="background:#F5F5F5;" + |Kawasaki Disease Diagnostic Criteria
| align="left" style="background:#F5F5F5;" + |Diagnoses Kawasaki Disease
| align="center" style="background:#F5F5F5;" + |Criteria
|-
! align="center" style="background:#DCDCDC;" + |Heart failure
| align="left" style="background:#F5F5F5;" + |Killip Classification for Heart Failure
| align="left" style="background:#F5F5F5;" + |Quantifies severity of heart failure in ACS and predicts 30-day mortality
| align="center" style="background:#F5F5F5;" + |Classification
|-
! align="center" style="background:#DCDCDC;" + |Readmission/Mortality
| align="left" style="background:#F5F5F5;" + |LACE Index for Readmission
| align="left" style="background:#F5F5F5;" + |Predicts 30-day readmission or death in patients on medicine and surgery wards
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |Heart failure/Mortality
| align="left" style="background:#F5F5F5;" + |MAGGIC Risk  for Heart Failure
| align="left" style="background:#F5F5F5;" + |Estimates 1- and 3- year mortality in heart failure
| align="center" style="background:#F5F5F5;" + |Score
|-
|-
! align="center" style="background:#DCDCDC;" + |VTE
! align="center" style="background:#DCDCDC;" + |Metabolic syndrome
| align="left" style="background:#F5F5F5;" + |[[Caprini score calculator]]
| align="left" style="background:#F5F5F5;" + |Metabolic Syndrome Criteria (AHA/NHLBI 2005)
| align="left" style="background:#F5F5F5;" + |[[User:Ssharfaei|Sadaf Sharfaei]]
| align="left" style="background:#F5F5F5;" + |Assists to diagnose and manage metabolic syndrome
| align="left" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Criteria
| align="left" style="background:#F5F5F5;" + |Completed
|-
|-
! align="center" style="background:#DCDCDC;" + |VTE
! align="center" style="background:#DCDCDC;" + |Metabolic syndrome
| align="left" style="background:#F5F5F5;" + |[[IMPROVE risk score calculator]]
| align="left" style="background:#F5F5F5;" + |Metabolic Syndrome Criteria (ATP III)
| align="left" style="background:#F5F5F5;" + |[[User:Ssharfaei|Sadaf Sharfaei]]
| align="left" style="background:#F5F5F5;" + |Diagnoses of metabolic syndrome
| align="left" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Criteria
| align="left" style="background:#F5F5F5;" + |Completed
|-
|-
! align="center" style="background:#DCDCDC;" + |VTE
! align="center" style="background:#DCDCDC;" + |Dyspnea
| align="left" style="background:#F5F5F5;" + |[[IMPROVEDD risk score calculator]]
| align="left" style="background:#F5F5F5;" + |mMRC (Modified Medical Research Council) Dyspnea Scale
| align="left" style="background:#F5F5F5;" + |[[User:Ssharfaei|Sadaf Sharfaei]]
| align="left" style="background:#F5F5F5;" + |Stratifies severity of dyspnea in respiratory diseases, particularly COPD
| align="left" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Classification
| align="left" style="background:#F5F5F5;" + |Completed
|-
|-
! align="center" style="background:#DCDCDC;" + |VTE
! align="center" style="background:#DCDCDC;" + |Mortality
| align="left" style="background:#F5F5F5;" + |[[Padua prediction score]]
| align="left" style="background:#F5F5F5;" + |Modified Early Warning Score (MEWS) for Clinical Deterioration
| align="left" style="background:#F5F5F5;" + |[[User:Ssharfaei|Sadaf Sharfaei]]
| align="left" style="background:#F5F5F5;" + |Determines the degree of illness of a patient
| align="left" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Score
| align="left" style="background:#F5F5F5;" + |Completed
|-
|-
| align="center" style="background:#DCDCDC;" + |MACE
! align="center" style="background:#DCDCDC;" + |Chest pain
| align="left" style="background:#F5F5F5;" + |HEART Score for Major Cardiac  Events
| align="left" style="background:#F5F5F5;" + |Newsom Score for Non-traumatic Chest Pain
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Rules out need for chest x-ray in chest pain patients (non-traumatic)
| align="left" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Criteria
| align="left" style="background:#F5F5F5;" + |
|-
|-
| align="center" style="background:#DCDCDC;" + |Blood pressure
! align="center" style="background:#DCDCDC;" + |Pacer
| align="left" style="background:#F5F5F5;" + |Mean Arterial Pressure (MAP)
| align="left" style="background:#F5F5F5;" + |Pacer Need After Heart Valve Surgery
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Predicts the need for permanent pacing after cardiac valve surgery
| align="left" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Score
| align="left" style="background:#F5F5F5;" + |
|-
|-
| align="center" style="background:#DCDCDC;" + |ECG
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |Corrected QT Interval (QTc)
| align="left" style="background:#F5F5F5;" + |Pediatric Early Warning Score (PEWS)
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Identifies pediatric patients at risk for clinical deterioration
| align="left" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Score
| align="left" style="background:#F5F5F5;" + |
|-
|-
| align="center" style="background:#DCDCDC;" + |PE
! align="center" style="background:#DCDCDC;" + |PE
| align="left" style="background:#F5F5F5;" + |PERC Rule for Pulmonary Embolism
| align="left" style="background:#F5F5F5;" + |PERC Rule for Pulmonary Embolism
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Rules out PE if no criteria are present and pre-test probability is ≤15%
| align="left" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Criteria
| align="left" style="background:#F5F5F5;" + |
|-
! align="center" style="background:#DCDCDC;" + |Operation
| align="left" style="background:#F5F5F5;" + |PTCA Mortality Prediction
| align="left" style="background:#F5F5F5;" + |Predicts the risk of major in-hospital complications following percutaneous coronary interventions
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |Pulmonary arterial hypertension
| align="left" style="background:#F5F5F5;" + |REVEAL Registry Risk Score for Pulmonary Arterial Hypertension (PAH)
| align="left" style="background:#F5F5F5;" + |Predicts survival in patients with pulmonary arterial hypertension
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |Stroke
| align="left" style="background:#F5F5F5;" + |Risk of Paradoxical Embolism (RoPE) Score
| align="left" style="background:#F5F5F5;" + |Identifies stroke-related PFO in patients with cryptogenic stroke
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |Imaging
| align="left" style="background:#F5F5F5;" + |Romhilt-Estes Criteria for Left Ventricular Hypertrophy
| align="left" style="background:#F5F5F5;" + |Electrocardiographic criteria for the diagnosis of left ventricular hypertrophy
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |Syncope
| align="left" style="background:#F5F5F5;" + |San Francisco Syncope Rule
| align="left" style="background:#F5F5F5;" + |Defines high-risk criteria for patients with syncope
| align="center" style="background:#F5F5F5;" + |Criteria
|-
! align="center" style="background:#DCDCDC;" + |Coronary artery disease
| align="left" style="background:#F5F5F5;" + |[[Sgarbossa's criteria]]
| align="left" style="background:#F5F5F5;" + |Assists to diagnose acute [[ST elevation myocardial infarction|MI]] in patients with [[Left bundle branch block|LBBB]]
| align="center" style="background:#F5F5F5;" + |Criteria
|-
! align="center" style="background:#DCDCDC;" + |Imaging
| align="left" style="background:#F5F5F5;" + |Stress Test Outcome Risk Factors
| align="left" style="background:#F5F5F5;" + |Predicts outcome in a community-based population undergoing stress testing
| align="center" style="background:#F5F5F5;" + |Score
|-
! align="center" style="background:#DCDCDC;" + |Stroke
| align="left" style="background:#F5F5F5;" + |tPA Contraindications for Ischemic Stroke
| align="left" style="background:#F5F5F5;" + |Provides inclusion/exclusion criteria when deciding to use tPA on a patient with acute ischemic stroke
| align="center" style="background:#F5F5F5;" + |Criteria
|-
! align="center" style="background:#DCDCDC;" + |Coronary artery disease
| align="left" style="background:#F5F5F5;" + |Troponin-only Manchester Acute Coronary Syndromes (T-MACS) Decision Aid
| align="left" style="background:#F5F5F5;" + |Rules out acute coronary syndrome
| align="center" style="background:#F5F5F5;" + |Criteria
|-
|-
| align="center" style="background:#DCDCDC;" + |Pre-operative risk
! align="center" style="background:#DCDCDC;" + |Coronary artery disease
| align="left" style="background:#F5F5F5;" + |Revised Cardiac Risk Index for Pre-Operative Risk
| align="left" style="background:#F5F5F5;" + |Unstable Angina and Tirofiban Benefit Prediction
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Predicts adverse outcomes and magnitude of benefit with glycoprotein IIb/IIIa inhibitor therapy in patients with unstable angina pectoris
| align="left" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Score
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |Coronary artery disease
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Unstable Angina Risk Stratification (Piombo)
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Predicts stratify risk in unstable angina
| align="left" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Score
| align="left" style="background:#F5F5F5;" + |
|-
|-
!
! align="center" style="background:#DCDCDC;" + |Coronary artery disease
!
| align="left" style="background:#F5F5F5;" + |Unstable Angina Risk Stratification (Solomon)
!
| align="left" style="background:#F5F5F5;" + |Identifies patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy
!
| align="center" style="background:#F5F5F5;" + |Score
!
|-
|-
|}
|}
Line 170: Line 479:
</div>
</div>


<div class="mw-collapsible">
<div class="mw-collapsible mw-collapsed">


==CRITICAL CARE==
==CRITICAL CARE==
Line 179: Line 488:
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Topic
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Topic
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Calculators
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Calculators
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Author
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Purpose
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Reviewer
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Status
|-
|-
! align="center" style="background:#DCDCDC;" + |Stroke
! align="center" style="background:#DCDCDC;" + |Stroke
| align="left" style="background:#F5F5F5;" + |[[Cincinnati stroke scale]]
| align="left" style="background:#F5F5F5;" + |[[Cincinnati stroke scale]]
| align="left" style="background:#F5F5F5;" + |[[User:Ssharfaei|Sadaf Sharfaei]]
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Completed
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |Sepsis
| align="left" style="background:#F5F5F5;" + |SIRS, Sepsis, and Septic Shock Criteria
| align="left" style="background:#F5F5F5;" + |SIRS, Sepsis, and Septic Shock Criteria
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |Sepsis
| align="left" style="background:#F5F5F5;" + |qSOFA (Quick SOFA) Score for  Sepsis
| align="left" style="background:#F5F5F5;" + |qSOFA (Quick SOFA) Score for  Sepsis
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |Mortality
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Modified Early Warning Score (MEWS) for Clinical Deterioration
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Determines the degree of illness of a patient.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
Line 241: Line 530:
</div>
</div>


<div class="mw-collapsible">
<div class="mw-collapsible mw-collapsed">
==GASTROENTEROLOGY==
==GASTROENTEROLOGY==
<div class="mw-collapsible-content">
<div class="mw-collapsible-content">
Line 249: Line 538:
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Topic
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Topic
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Calculators
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Calculators
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Author
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Purpose
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Reviewer
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Status
|-
|-
! align="center" style="background:#DCDCDC;" + |Liver disease
! align="center" style="background:#DCDCDC;" + |Liver disease
| align="left" style="background:#F5F5F5;" + |[[MELD Score]]
| align="left" style="background:#F5F5F5;" + |[[MELD Score]]
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Liver disease
! align="center" style="background:#DCDCDC;" + |Liver disease
| align="left" style="background:#F5F5F5;" + |Child-Pugh Score for Cirrhosis Mortality
| align="left" style="background:#F5F5F5;" + |Child-Pugh score for cirrhosis mortality
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Pancreatitis  
! align="center" style="background:#DCDCDC;" + |Pancreatitis  
| align="left" style="background:#F5F5F5;" + |[[Ranson criteria]]
| align="left" style="background:#F5F5F5;" + |[[Ranson criteria]]
| align="left" style="background:#F5F5F5;" + |[[User:Ssharfaei|Sadaf Sharfaei]]
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Completed
|-
|-
! align="center" style="background:#DCDCDC;" + |Pericarditis  
! align="center" style="background:#DCDCDC;" + |Pericarditis  
| align="left" style="background:#F5F5F5;" + |[[Tygerberg score]]
| align="left" style="background:#F5F5F5;" + |[[Tygerberg score]]
| align="left" style="background:#F5F5F5;" + |[[User:Ssharfaei|Sadaf Sharfaei]]
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Completed
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
Line 305: Line 576:
</div>
</div>


<div class="mw-collapsible">
<div class="mw-collapsible mw-collapsed">
==HEMATOLOGY/ONCOLOGY==
==HEMATOLOGY/ONCOLOGY==
<div class="mw-collapsible-content">
<div class="mw-collapsible-content">
Line 313: Line 584:
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Topic
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Topic
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Calculators
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Calculators
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Author
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Purpose
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Reviewer
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Status
|-
|-
! align="center" style="background:#DCDCDC;" + |Myelofibrosis
! align="center" style="background:#DCDCDC;" + |Myelofibrosis
| align="left" style="background:#F5F5F5;" + |[[DIPSS Plus Score]]
| align="left" style="background:#F5F5F5;" + |[[DIPSS Plus Score]]
| align="left" style="background:#F5F5F5;" + |[[User:Ssharfaei|Sadaf Sharfaei]]
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Completed
|-
|-
! align="center" style="background:#DCDCDC;" + |CBC
! align="center" style="background:#DCDCDC;" + |CBC
| align="left" style="background:#F5F5F5;" + |Absolute Neutrophil Count (ANC)
| align="left" style="background:#F5F5F5;" + |Absolute Neutrophil Count (ANC)
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
Line 369: Line 622:
</div>
</div>


<div class="mw-collapsible">
<div class="mw-collapsible mw-collapsed">
==INFECTIOUS DISEASE==
==INFECTIOUS DISEASE==
<div class="mw-collapsible-content">
<div class="mw-collapsible-content">
Line 377: Line 630:
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Topic
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Topic
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Calculators
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Calculators
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Author
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Purpose
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Reviewer
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Status
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |ENT
| align="left" style="background:#F5F5F5;" + |Centor Score (Modified/McIsaac) for Strep Pharyngitis
| align="left" style="background:#F5F5F5;" + |Centor Score (Modified/McIsaac) for Strep Pharyngitis
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |Infective endocarditis/Mortality
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Infective Endocarditis (IE) Mortality Risk Score
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Predicts mortality at 6 months in patients with infective endocarditis.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
Line 433: Line 668:
</div>
</div>


<div class="mw-collapsible">
<div class="mw-collapsible mw-collapsed">
==NEPHROLOGY==
==NEPHROLOGY==
<div class="mw-collapsible-content">
<div class="mw-collapsible-content">
Line 441: Line 676:
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Topic
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Topic
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Calculators
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Calculators
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Author
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Purpose
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Reviewer
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Status
|-
|-
| align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |Creatinine Clearance
| align="left" style="background:#F5F5F5;" + |Creatinine clearance
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
| align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |Sodium Correction for Hyperglycemia
| align="left" style="background:#F5F5F5;" + |Sodium correction for hyperglycemia
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
| align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |Fractional Excretion of Sodium (FENa)
| align="left" style="background:#F5F5F5;" + |Fractional Excretion of Sodium (FENa)
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |Calcium correction for hypoalbuminemia
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
! align="center" style="background:#DCDCDC;" + |Fluid
| align="left" style="background:#F5F5F5;" + |Maintenance fluids calculations
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
| align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |Nephropathy
| align="left" style="background:#F5F5F5;" + |Mehran Score for Post-PCI Contrast Nephropathy
| align="left" style="background:#F5F5F5;" + |Predicts risk of contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI).
|-
! align="center" style="background:#DCDCDC;" + |Electrolytes
| align="left" style="background:#F5F5F5;" + |Calcium Correction for Hypoalbuminemia
| align="left" style="background:#F5F5F5;" + |Calcium Correction for Hypoalbuminemia
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Calculates a corrected calcium level for patients with hypoalbuminemia.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
| align="center" style="background:#DCDCDC;" + |Fluid
! align="center" style="background:#DCDCDC;" + |Fluid
| align="left" style="background:#F5F5F5;" + |Maintenance Fluids Calculations
| align="left" style="background:#F5F5F5;" + |Maintenance Fluids Calculations
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Calculates maintenance fluid requirements by weight.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |Renal Artery Stenosis
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |PTCA Mortality Prediction
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |A Clinical Prediction Rule for Renal Artery Stenosis
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
!Fluid
| align="left" style="background:#F5F5F5;" + |
|Urine Output and Fluid Balance
| align="left" style="background:#F5F5F5;" + |
|Calculates urine output over a 24-hour period.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
|}
|}
Line 503: Line 722:
</div>
</div>


<div class="mw-collapsible">
<div class="mw-collapsible mw-collapsed">
==NEUROLOGY==
==NEUROLOGY==
<div class="mw-collapsible-content">
<div class="mw-collapsible-content">
Line 511: Line 730:
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Topic
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Topic
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Calculators
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Calculators
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Author
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Purpose
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Reviewer
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Status
|-
|-
! align="center" style="background:#DCDCDC;" + |Level of consciousness
! align="center" style="background:#DCDCDC;" + |Level of consciousness
| align="left" style="background:#F5F5F5;" + |[[Glasgow coma scale]]
| align="left" style="background:#F5F5F5;" + |[[Glasgow coma scale]]
| align="left" style="background:#F5F5F5;" + |[[User:Ssharfaei|Sadaf Sharfaei]]
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Completed
|-
|-
! align="center" style="background:#DCDCDC;" + |Level of consciousness
! align="center" style="background:#DCDCDC;" + |Level of consciousness
| align="left" style="background:#F5F5F5;" + |[[Pediatric Glasgow Coma Scale]]
| align="left" style="background:#F5F5F5;" + |[[Pediatric Glasgow Coma Scale]]
| align="left" style="background:#F5F5F5;" + |[[User:Ssharfaei|Sadaf Sharfaei]]
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Completed
|-
|-
! align="center" style="background:#DCDCDC;" + |Stroke
! align="center" style="background:#DCDCDC;" + |Stroke
| align="left" style="background:#F5F5F5;" + |[[Cincinnati stroke scale]]
| align="left" style="background:#F5F5F5;" + |[[Cincinnati stroke scale]]
| align="left" style="background:#F5F5F5;" + |[[User:Ssharfaei|Sadaf Sharfaei]]
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Completed
|-
|-
| align="center" style="background:#DCDCDC;" + |Stroke
! align="center" style="background:#DCDCDC;" + |Stroke
| align="left" style="background:#F5F5F5;" + |NIH Stroke Scale/Score (NIHSS)
| align="left" style="background:#F5F5F5;" + |NIH Stroke Scale/Score (NIHSS)
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |Arrythmia/Stroke
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Atrial Fibrillation Five Year Risk of Stroke (Framingham Heart Study)
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Predicts 5-year risk of stroke in patients with atrial fibrillation
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |Arrythmia/Stroke
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Atrial Fibrillation Five Year Risk of Stroke or Death (Framingham Heart Study)
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Predicts 5-year risk of stroke or death in patients with atrial fibrillation
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |Stroke/Mortality
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |SOAR Score for Stroke, modified
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Predicts short-term mortality in acute ischemic stroke.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |Bleeding
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Intracranial Bleeding Risk from Thrombolytic Therapy of MI
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Estimates the risk of intracranial hemorrhage associated with thrombolytic therapy among MI patients
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
Line 573: Line 772:
</div>
</div>


<div class="mw-collapsible">
<div class="mw-collapsible mw-collapsed">
==PEDIATRICS==
==PEDIATRICS==
<div class="mw-collapsible-content">
<div class="mw-collapsible-content">
Line 581: Line 780:
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Topic
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Topic
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Calculators
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Calculators
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Author
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Purpose
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Reviewer
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Status
|-
|-
! align="center" style="background:#DCDCDC;" + |Level of consciousness
! align="center" style="background:#DCDCDC;" + |Level of consciousness
| align="left" style="background:#F5F5F5;" + |[[Pediatric Glasgow Coma Scale]]
| align="left" style="background:#F5F5F5;" + |[[Pediatric Glasgow Coma Scale]]
| align="left" style="background:#F5F5F5;" + |[[User:Ssharfaei|Sadaf Sharfaei]]
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Completed
|-
|-
! align="center" style="background:#DCDCDC;" + |Neonatology
! align="center" style="background:#DCDCDC;" + |Neonatology
| align="left" style="background:#F5F5F5;" + |[[Apgar score]]
| align="left" style="background:#F5F5F5;" + |[[Apgar score]]
| align="left" style="background:#F5F5F5;" + |[[User:Ssharfaei|Sadaf Sharfaei]]
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Completed
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Pediatric Early Warning Score (PEWS)
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Identifies pediatric patients at risk for clinical deterioration.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
Line 637: Line 818:
</div>
</div>


<div class="mw-collapsible">
<div class="mw-collapsible mw-collapsed">


==PULMONOLOGY==
==PULMONOLOGY==
Line 646: Line 827:
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Topic
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Topic
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Calculators
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Calculators
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Author
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Purpose
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Reviewer
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Status
|-
|-
! align="center" style="background:#DCDCDC;" + |Pneumonia
! align="center" style="background:#DCDCDC;" + |Pneumonia
| align="left" style="background:#F5F5F5;" + |[[CURB-65]]
| align="left" style="background:#F5F5F5;" + |[[CURB-65]]
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Pneumonia
! align="center" style="background:#DCDCDC;" + |Pneumonia
| align="left" style="background:#F5F5F5;" + |[[Pneumonia severity index]]
| align="left" style="background:#F5F5F5;" + |[[Pneumonia severity index]]
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Pulmonary Vascular Resistance
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Calculates the pulmonary vascular resistance
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |
! align="center" style="background:#DCDCDC;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
Line 702: Line 865:
</div>
</div>


<div class="mw-collapsible">
<div class="mw-collapsible mw-collapsed">
==ORTHOPEDICS==
==ORTHOPEDICS==
<div class="mw-collapsible-content">
<div class="mw-collapsible-content">
Line 710: Line 873:
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Topic
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Topic
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Calculators
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Calculators
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Author
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Purpose
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Reviewer
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Status
|-
|-
! align="center" style="background:#DCDCDC;" + |Open Fractures
! align="center" style="background:#DCDCDC;" + |Open Fractures
| align="left" style="background:#F5F5F5;" + |Mangled Extremity Score
| align="left" style="background:#F5F5F5;" + |Mangled Extremity Score
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Clinician completed the score to determine which mangled limbs will eventually come to amputation.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Open Fractures
! align="center" style="background:#DCDCDC;" + |Open Fractures
| align="left" style="background:#F5F5F5;" + |Ganga Hospital Open Injury Score (GHOIS)
| align="left" style="background:#F5F5F5;" + |Ganga Hospital Open Injury Score (GHOIS)
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Clinician completed the score to help them in decision making regarding salvage in IIIB injuries.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Knee (Anterior Cruciate Ligament)
! align="center" style="background:#DCDCDC;" + |Knee (Anterior Cruciate Ligament)
| align="left" style="background:#F5F5F5;" + |Modified Cincinnati Rating system
| align="left" style="background:#F5F5F5;" + |Modified Cincinnati Rating system
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Clinician and patient completed the score for evaluation of functional activity levels after surgery.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Knee (Anterior Cruciate Ligament)
! align="center" style="background:#DCDCDC;" + |Knee (Anterior Cruciate Ligament)
| align="left" style="background:#F5F5F5;" + |Tegner Lysholm Knee Scoring Scale
| align="left" style="background:#F5F5F5;" + |Tegner Lysholm Knee Scoring Scale
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Clinician and patient completed score for evaluation of functional activity levels after surgery.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Knee (Anterior Cruciate Ligament)
! align="center" style="background:#DCDCDC;" + |Knee (Anterior Cruciate Ligament)
| align="left" style="background:#F5F5F5;" + |KOOS (Knee Injury & Osteoarthritis Outcome)
| align="left" style="background:#F5F5F5;" + |KOOS (Knee Injury & Osteoarthritis Outcome)
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Patient completed the score to assess response to surgery and physical therapy for patients undergoing anterior cruciate ligament reconstruction.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Knee (Osteoarthritis)
! align="center" style="background:#DCDCDC;" + |Knee (Osteoarthritis)
| align="left" style="background:#F5F5F5;" + |Oxford Knee Score
| align="left" style="background:#F5F5F5;" + |Oxford Knee Score
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Patient completed score to assess the severity of disability from osteoarthritis before and after 6 months of surgery.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Knee (Osteoarthritis)
! align="center" style="background:#DCDCDC;" + |Knee (Osteoarthritis)
| align="left" style="background:#F5F5F5;" + |KOOS (Knee Injury & Osteoarthritis  Outcome)
| align="left" style="background:#F5F5F5;" + |KOOS (Knee Injury & Osteoarthritis  Outcome)
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Patient completed the score to assess severity in patients with osteoarthritis.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Knee (Osteoarthritis)
! align="center" style="background:#DCDCDC;" + |Knee (Osteoarthritis)
| align="left" style="background:#F5F5F5;" + |WOMAC Score
| align="left" style="background:#F5F5F5;" + |WOMAC Score
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Patient completed the score for measuring quality of life (QOL) in patient suffering from osteoarthritis.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Knee (Osteoarthritis)
! align="center" style="background:#DCDCDC;" + |Knee (Osteoarthritis)
| align="left" style="background:#F5F5F5;" + |IKDC
| align="left" style="background:#F5F5F5;" + |IKDC
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Patient completed the score for evaluation of functional activity levels.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Knee (Osteoarthritis)
! align="center" style="background:#DCDCDC;" + |Knee (Osteoarthritis)
| align="left" style="background:#F5F5F5;" + |Knee Society Score (KSS)
| align="left" style="background:#F5F5F5;" + |Knee Society Score (KSS)
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Clinician completed score to assess objective knee disability, patient satisfaction and expectation level, and functional activity level.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Foot/Ankle
! align="center" style="background:#DCDCDC;" + |Foot/Ankle
| align="left" style="background:#F5F5F5;" + |American Foot & Ankle Score
| align="left" style="background:#F5F5F5;" + |American Foot & Ankle Score
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Clinician completed the score to provide a standard method of reporting clinical status of the ankle and foot.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Foot/Ankle
! align="center" style="background:#DCDCDC;" + |Foot/Ankle
| align="left" style="background:#F5F5F5;" + |Foot & Ankle Disability Index
| align="left" style="background:#F5F5F5;" + |Foot & Ankle Disability Index
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Patient completed the score for to assess functional limitations related to foot and ankle conditions.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Wrist
! align="center" style="background:#DCDCDC;" + |Wrist
| align="left" style="background:#F5F5F5;" + |MAYO Wrist Score
| align="left" style="background:#F5F5F5;" + |MAYO Wrist Score
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Clinician completed the score to assess the outcome folowign management of scaphoid fractures.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Wrist
! align="center" style="background:#DCDCDC;" + |Wrist
| align="left" style="background:#F5F5F5;" + |DASH (Disabilities of arm, shoulder & hand) Score
| align="left" style="background:#F5F5F5;" + |DASH (Disabilities of arm, shoulder & hand) Score
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Patient completed the score to measure physical function and symptoms in patients with musculoskeletal disorders of the upper limb.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Wrist
! align="center" style="background:#DCDCDC;" + |Wrist
| align="left" style="background:#F5F5F5;" + |Quick-DASH Score
| align="left" style="background:#F5F5F5;" + |Quick-DASH Score
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Patient completed score to determine the disability experienced by patients with any musculoskeletal condition of the upper extremity and to monitor change in symptoms and upper limb function over time. It is a shortened version of the DASH.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Hand
! align="center" style="background:#DCDCDC;" + |Hand
| align="left" style="background:#F5F5F5;" + |Michigan Hand Outcomes Questionnaire
| align="left" style="background:#F5F5F5;" + |Michigan Hand Outcomes Questionnaire
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Patient completed the score which allowed assessment of activity of daily living in patients with hand disability.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Hand
! align="center" style="background:#DCDCDC;" + |Hand
| align="left" style="background:#F5F5F5;" + |DASH (Disabilities of arm, shoulder & hand) Score
| align="left" style="background:#F5F5F5;" + |DASH (Disabilities of arm, shoulder & hand) Score
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Patient completed the score to measure physical function and symptoms in patients with musculoskeletal disorders of the upper limb.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Hand
! align="center" style="background:#DCDCDC;" + |Hand
| align="left" style="background:#F5F5F5;" + |Quick-DASH Score
| align="left" style="background:#F5F5F5;" + |Quick-DASH Score
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Patient completed score to determine the disability experienced by patients with any musculoskeletal condition of the upper extremity and to monitor change in symptoms and upper limb function over time. It is a shortened version of the DASH.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Lumbar Spine
! align="center" style="background:#DCDCDC;" + |Lumbar Spine
| align="left" style="background:#F5F5F5;" + |Oswestry Low Back Pain Score
| align="left" style="background:#F5F5F5;" + |Oswestry Low Back Pain Score
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Patient completed the score to determine the disability experienced by patients with low back pain.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Lumbar Spine
! align="center" style="background:#DCDCDC;" + |Lumbar Spine
| align="left" style="background:#F5F5F5;" + |Modified Oswestry Low Back Pain Score
| align="left" style="background:#F5F5F5;" + |Modified Oswestry Low Back Pain Score
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Patient completed score to determine the disability experienced by patients with low back pain before and after the surgery.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Lumbar Spine
! align="center" style="background:#DCDCDC;" + |Lumbar Spine
| align="left" style="background:#F5F5F5;" + |Back Pain Index
| align="left" style="background:#F5F5F5;" + |Back Pain Index
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Patient completed the score to determine how back condition affects their everyday life.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Cervical Spine
! align="center" style="background:#DCDCDC;" + |Cervical Spine
| align="left" style="background:#F5F5F5;" + |Vernon & Mior Cervical Spine Score
| align="left" style="background:#F5F5F5;" + |Vernon & Mior Cervical Spine Score
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Patient completed score to how their neck pain has affected their ability to manage in everyday life.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Hip
! align="center" style="background:#DCDCDC;" + |Hip
| align="left" style="background:#F5F5F5;" + |Harris Hip Score
| align="left" style="background:#F5F5F5;" + |Harris Hip Score
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Clinician completed score for the assessment of the results of hip surgery, and is intended to evaluate various hip disabilities and methods of treatment in an adult population.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Hip
! align="center" style="background:#DCDCDC;" + |Hip
| align="left" style="background:#F5F5F5;" + |Oxford Hip Score
| align="left" style="background:#F5F5F5;" + |Oxford Hip Score
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Patient completed score for to assess outcome after total hip replacement (THR) by measuring patients' perceptions in adjunction to surgery.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Hip
! align="center" style="background:#DCDCDC;" + |Hip
| align="left" style="background:#F5F5F5;" + |HOOS (Hip disability and Osteoarthritis Outcome)
| align="left" style="background:#F5F5F5;" + |HOOS (Hip disability and Osteoarthritis Outcome)
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Patient completed the score to give their opinion about their hip and associated problems, and is intended to be used in an adult population with hip disability with or without osteoarthritis.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Hip
! align="center" style="background:#DCDCDC;" + |Hip
| align="left" style="background:#F5F5F5;" + |WOMAC Score
| align="left" style="background:#F5F5F5;" + |WOMAC Score
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Patient completed score for for measuring quality of life (QOL) in patient suffering from osteoarthritis.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Shoulder
! align="center" style="background:#DCDCDC;" + |Shoulder
| align="left" style="background:#F5F5F5;" + |Constant Shoulder Score
| align="left" style="background:#F5F5F5;" + |Constant Shoulder Score
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Clinician completed the score for clinical functional assessment for shoulder complaints before and after surgery.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Shoulder
! align="center" style="background:#DCDCDC;" + |Shoulder
| align="left" style="background:#F5F5F5;" + |UCLA Shoulder rating scale
| align="left" style="background:#F5F5F5;" + |UCLA Shoulder rating scale
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Clinician completed the score to assess diability, pain and patient satisfaction.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Shoulder
! align="center" style="background:#DCDCDC;" + |Shoulder
| align="left" style="background:#F5F5F5;" + |Oxford Shoulder Score
| align="left" style="background:#F5F5F5;" + |Oxford Shoulder Score
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Patient completed the score for assessment of pain and function of the shoulder.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Shoulder
! align="center" style="background:#DCDCDC;" + |Shoulder
| align="left" style="background:#F5F5F5;" + |American Shoulder And Elbow Surgeons (ASES) Society Score
| align="left" style="background:#F5F5F5;" + |American Shoulder And Elbow Surgeons (ASES) Society Score
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Patient completed the score for assessing activities of daily living (ADL).
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Shoulder
! align="center" style="background:#DCDCDC;" + |Shoulder
| align="left" style="background:#F5F5F5;" + |DASH (Disabilities of arm, shoulder & hand) Score
| align="left" style="background:#F5F5F5;" + |DASH (Disabilities of arm, shoulder & hand) Score
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Patient completed the score to measure physical function and symptoms in patients with musculoskeletal disorders of the upper limb.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Shoulder
! align="center" style="background:#DCDCDC;" + |Shoulder
| align="left" style="background:#F5F5F5;" + |Quick-DASH Score
| align="left" style="background:#F5F5F5;" + |Quick-DASH Score
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Patient completed score to determine the disability experienced by patients with any musculoskeletal condition of the upper extremity and to monitor change in symptoms and upper limb function over time. It is a shortened version of the DASH.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Shoulder (Instability)
! align="center" style="background:#DCDCDC;" + |Shoulder (Instability)
| align="left" style="background:#F5F5F5;" + |Rowe Score for Instability
| align="left" style="background:#F5F5F5;" + |Rowe Score for Instability
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Clinician completed the score for assessing stability, motion and function after the surgery for shoulder instability.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Shoulder (Instability)
! align="center" style="background:#DCDCDC;" + |Shoulder (Instability)
| align="left" style="background:#F5F5F5;" + |Oxford Shoulder Instability Score
| align="left" style="background:#F5F5F5;" + |Oxford Shoulder Instability Score
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Patient completed score for assessing the outcome of treatment for shoulder instability.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Shoulder (Instability)
! align="center" style="background:#DCDCDC;" + |Shoulder (Instability)
| align="left" style="background:#F5F5F5;" + |WOSI (Western Ontario Shoulder Instability Index)
| align="left" style="background:#F5F5F5;" + |WOSI (Western Ontario Shoulder Instability Index)
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Patient completed the score for measuring disease-specific quality of life in patient suffering from shoulder instability.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Elbow
! align="center" style="background:#DCDCDC;" + |Elbow
| align="left" style="background:#F5F5F5;" + |MAYO Elbow Score
| align="left" style="background:#F5F5F5;" + |MAYO Elbow Score
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Clinician completed the score for evaluating disability associated with elbow injuries.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Elbow
! align="center" style="background:#DCDCDC;" + |Elbow
| align="left" style="background:#F5F5F5;" + |Oxford Elbow Score
| align="left" style="background:#F5F5F5;" + |Oxford Elbow Score
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Patient completed score to measures injury-related quality of life in patients following surgery of the elbow joint
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Elbow
! align="center" style="background:#DCDCDC;" + |Elbow
| align="left" style="background:#F5F5F5;" + |DASH (Disabilities of arm, shoulder & hand) Score
| align="left" style="background:#F5F5F5;" + |DASH (Disabilities of arm, shoulder & hand) Score
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Patient completed the score to measure physical function and symptoms in patients with musculoskeletal disorders of the upper limb.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Elbow
! align="center" style="background:#DCDCDC;" + |Elbow
| align="left" style="background:#F5F5F5;" + |Quick-DASH Score
| align="left" style="background:#F5F5F5;" + |Quick-DASH Score
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Patient completed score to determine the disability experienced by patients with any musculoskeletal condition of the upper extremity and to monitor change in symptoms and upper limb function over time. It is a shortened version of the DASH.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |VAS
! align="center" style="background:#DCDCDC;" + |VAS
| align="left" style="background:#F5F5F5;" + |VAS Score
| align="left" style="background:#F5F5F5;" + |VAS Score
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Clinician and patient completed the score for evaluation of pain severity and relief.
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |Psychological
! align="center" style="background:#DCDCDC;" + |Psychological
| align="left" style="background:#F5F5F5;" + |DRAM (Distress and Risk Assessment Method)
| align="left" style="background:#F5F5F5;" + |DRAM (Distress and Risk Assessment Method)
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |Patient completed the score to measure psychological distress in patients presenting for orthopaedic care.
| align="left" style="background:#F5F5F5;" + |
|-
| align="left" style="background:#F5F5F5;" + |
|}
</div>
</div>
 
<div class="mw-collapsible mw-collapsed">
==SURGERY==
<div class="mw-collapsible-content">
 
{| class="wikitable sortable"
|-
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Topic
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Calculators
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Purpose
|-
! align="center" style="background:#DCDCDC;" + |MACE
| align="left" style="background:#F5F5F5;" + |Cardiac Risk Index for AAA Surgery (Lee)
| align="left" style="background:#F5F5F5;" + |Calculates the approximate risk of cardiac complication after AAA surgery
|-
! align="center" style="background:#DCDCDC;" + |MACE
| align="left" style="background:#F5F5F5;" + |Cardiac Risk Index for Abdominal Surgery (Lee)
| align="left" style="background:#F5F5F5;" + |Calculates the approximate risk of cardiac complication after abdominal surgery
|-
! align="center" style="background:#DCDCDC;" + |MACE
| align="left" style="background:#F5F5F5;" + |Cardiac Risk Index for Pre-Operative Risk, revised
| align="left" style="background:#F5F5F5;" + |Estimates risk of cardiac complications after noncardiac surgery.
|-
! align="center" style="background:#DCDCDC;" + |Anesthesia
| align="left" style="background:#F5F5F5;" + |Cardiac Anesthesia Risk Evaluation Score (CARE)
| align="left" style="background:#F5F5F5;" + |Predicts mortality and morbidity after cardiac surgery.
|-
! align="center" style="background:#DCDCDC;" + |MACE
| align="left" style="background:#F5F5F5;" + |EuroSCORE for Cardiac Surgery Risk Assessment
| align="left" style="background:#F5F5F5;" + |Estimates the mortality among cardiac surgical adult patients
|-
! align="center" style="background:#DCDCDC;" + |Pacer
| align="left" style="background:#F5F5F5;" + |Pacer Need After Heart Valve Surgery
| align="left" style="background:#F5F5F5;" + |Predicts the need for permanent pacing after cardiac valve surgery
|-
! align="center" style="background:#DCDCDC;" + |Operation
| align="left" style="background:#F5F5F5;" + |PTCA Mortality Prediction
| align="left" style="background:#F5F5F5;" + |Predicts the risk of major in-hospital complications following percutaneous coronary interventions
|-
! align="center" style="background:#DCDCDC;" + |Cradiac surgery
| align="left" style="background:#F5F5F5;" + |ACEF II Risk Score for Cardiac Surgery
| align="left" style="background:#F5F5F5;" + |Predicts 30-day mortality after elective or emergency cardiac surgery.
|-
! align="center" style="background:#DCDCDC;" + |Operation
| align="left" style="background:#F5F5F5;" + |Postoperative Cardiac Risk Prediction
| align="left" style="background:#F5F5F5;" + |calculates the prediction of cardiac risk after surgery
|-
|-
|}
|}

Latest revision as of 06:02, 10 February 2019

Calculator project
Introduction
Guide
Template
Topics
Validated Scores
Alphabetic Order

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]

CARDIOLOGY

Topic Calculators Purpose Type
Coronary artery disease ACTION ICU risk score Predicts need for ICU care in stable adults with NSTEMI Score
MACE ADAPT Protocol for Cardiac Event Risk Assesses chest pain patients at 2 hours for risk of cardiac event Score
DVT AMUSE score Evaluates the need to proceed with ultrasonography among patients with suspected DVT Score
Anticoagulation ATRIA bleeding risk score Determines bleeding risk for patients on warfarin Score
Arrythmia ATRIA stroke risk score Determines stroke risk in patients with atrial fibrillation Score
Arrythmia/Stroke Atrial fibrillation 5-year risk of stroke (Framingham Heart Study) Predicts 5-year risk of stroke in patients with atrial fibrillation Score
Arrythmia/Stroke Atrial fibrillation 5-year risk of stroke or death (Framingham Heart Study) Predicts 5-year risk of stroke or death in patients with atrial fibrillation Score
Alcoholism CAGE questions Screens for excessive drinking and alcoholism Score
Syncope Canadian syncope risk score Predicts 30-day serious adverse events in patients presenting with syncope Score
VTE Caprini score Stratifies risk of VTE in surgical patients Score
MACE Cardiac Risk Index for AAA Surgery (Lee) Calculates the approximate risk of cardiac complication after AAA surgery Score
MACE Cardiac Risk Index for Abdominal Surgery (Lee) Calculates the approximate risk of cardiac complication after abdominal surgery Score
MACE Cardiac Risk Index for Pre-Operative Risk, revised Estimates risk of cardiac complications after noncardiac surgery Score
MACE Cardiovascular Risk Assessment (10-year, PROCAM Score, Munster Heart Study) Predicts 10-year cardiovascular risk based on risk factors like history of MI, diabetes or high cholesterol Score
Cardiac arrest CART (Cardiac Arrest Risk Triage) Score Predicts risk of in-hospital cardiac arrest Score
Arrythmia/Stroke CHA₂DS₂-VASc Score for Atrial Fibrillation Stroke Risk Calculates stroke risk for patients with atrial fibrillation, possibly better than the CHADS₂ Score Score
Arrythmia/Stroke CHADS₂ Score for Atrial Fibrillation Stroke Risk Estimates stroke risk in patients with atrial fibrillation Score
Survival Charlson Comorbidity Index (CCI) Predicts 10-year survival in patients with multiple comorbidities Score
Stroke Cincinnati Prehospital Stroke Severity Scale (CP-SSS) Predicts large vessel occlusion (LVO) and severe stroke in patients with stroke symptoms Score
Coronary artery disease/Bleeding CRUSADE Score for Post-MI Bleeding Risk Stratifies bleeding risk after NSTEMI Score
VTE DASH prediction score Predicts disease recurrence in patients with prior unprovoked VTE Score
Coronary artery disease DAPT score Predicts which patients will benefit from prolonged dual antiplatelet therapy after coronary stent placement Score
Syncope EGSYS (Evaluation of Guidelines in SYncope Study) Score for Syncope Predicts likelihood that syncope is from cardiac cause Score
VTE Geneva Risk Score for Venous Thromboembolism (VTE) Prophylaxis Predicts need for VTE prophylaxis in admitted patients Score
PE Geneva score for PE, original Determines the pre-test probability of PE based on a patient's risk factors and clinical findings Score
PE Geneva score for PE, revised Objectifies risk of PE, like Wells’ score Score
PE Geneva score for PE, simplified Determines the pre-test probability of PE based on a patient's risk factors and clinical findings Score
Cardiac arrest/Survival GO-FAR (Good Outcome Following Attempted Resuscitation) Score Predicts survival to discharge with good outcome after in-hospital cardiac arrest Score
Coronary artery disease Grace Risk Score for All-Cause Mortality From Discharge to 6 Months Assesses the risk of 6-month mortality among patients with acute coronary syndrome Score
Coronary artery disease Grace Risk Score for In-Hospital Mortality Assesses the risk of in-hospital mortality among patients with acute coronary syndrome Score
DVT HAMILTON score Assesses the pretest probability of DVT among ambulatory outpatients Score
Bleeding HAS-BLED Score for Major Bleeding Risk Estimates risk of major bleeding for patients on anticoagulation to assess risk-benefit in atrial fibrillation care Score
Coronary artery disease HEART Pathway for Early Discharge in Acute Chest Pain Identifies emergency department patients with acute chest pain for early discharge Score
MACE HEART Score for Major Cardiac Events Predicts 6-week risk of major adverse cardiac event Score
Arrythmia/Bleeding HEMORR₂HAGES Score for Major Bleeding Risk Quantifies risk of hemorrhage in elderly patients with AFib Score
PE Hestia Criteria for Outpatient Pulmonary Embolism Treatment Identifies low-risk PE patients safe for outpatient treatment Score
Bleeding IMPROVE bleeding risk score Estimates the probability of major or clinically important in-hospital bleeding from the time of hospital admission up to 14 days following admission Score
VTE IMPROVE VTE risk score Estimates the probability of clinically evident acute venous thromboembolism from the time of hospital admission to discharge Score
VTE IMPROVEDD VTE risk score Estimates the probability of venous thromboembolism from the time of hospital admission up to 77 days Score
Infective endocarditis/Mortality Infective Endocarditis (IE) Mortality Risk Score Predicts mortality at 6 months in patients with infective endocarditis Score
Coronary artery disease Marburg Heart Score (MHS) Rules out coronary artery disease in primary care patients with chest pain Score
Nephropathy Mehran Score for Post-PCI Contrast Nephropathy Predicts risk of contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI) Score
Syncope/Mortality OESIL Score for Syncope Estimates 12-month all-cause mortality in patients presenting with syncope Score
Heart failure Ottawa Heart Failure Risk Scale (OHFRS) Identifies ED patients with heart failure at high risk for serious adverse events Score
VTE Padua Prediction Score for Risk of VTE Determines anticoagulation need in hospitalized patients by risk of VTE Score
PE PESI (Pulmonary Embolism Severity Index) Predicts 30-day outcome of patients with pulmonary embolism using 11 clinical criteria Score
PE PESI (Pulmonary Embolism Severity Index), simplified Predicts 30-day outcome of patients with PE, with fewer criteria than the original PESI Score
PE/Bleeding RIETE Score for Risk of Hemorrhage in Pulmonary Embolism Treatment Determine the risk of major bleeding during anticoagulant therapy Score
Stroke/Mortality SOAR Score for Stroke, modified Predicts short-term mortality in acute ischemic stroke Score
Coronary artery disease TIMI Risk Score for STEMI Estimates mortality in patients with STEMI Score
Coronary artery disease TIMI Risk Score for UA/NSTEMI Estimates mortality for patients with unstable angina and non-ST elevation MI Score
DVT Wells score for DVT (original) Estimates the pre-test probability of DVT Score
DVT Wells score for DVT (modified) Estimates the pre-test probability of DVT Score
PE Wells score for PE (original) Estimates the pre-test probability of PE Score
PE Wells score for PE (modified) Estimates the pre-test probability of PE Score
Anesthesia Cardiac Anesthesia Risk Evaluation Score (CARE) Predicts mortality and morbidity after cardiac surgery Score
Duke Activity Status Index (DASI) Estimates functional capacity Score
Ehlers-Danlos Syndrome Ehlers-Danlos Syndrome IV (vascular type) Diagnostic Criteria Diagnoses Ehlers-Danlos Syndrome IV (vascular type) Criteria
Coronary artery disease Emergency Department Assessment of Chest Pain Score (EDACS) Identifies chest pain patients with low risk of major adverse cardiac event Score
MACE EuroSCORE for Cardiac Surgery Risk Assessment Estimates the mortality among cardiac surgical adult patients Score
MACE Framingham 10 Year Coronary Risk Prediction by LDL (1998 paper) Predicts 10-year risk of coronary heart disease Score
MACE Framingham 10 Year Coronary Risk Prediction by Total Cholesterol (1998 paper) Predicts 10-year risk of coronary heart disease Score
MACE Framingham 10 Year Risk of General Cardiovascular Disease (2008 paper) Predicts 10-year risk of heart disease Score
Heart failure Framingham Heart Failure Diagnostic Criteria Diagnoses heart failure based on major and minor criteria Criteria
Heart failure GWTG-Heart Failure Risk Score Predicts in-hospital all-cause heart failure mortality Score
Takayasu arteritis Indian Takayasu Clinical Activity Score (ITAS2010) Differentiates between active and inactive disease in Takayasu arteritis (TA) Score
Bleeding Intracranial Bleeding Risk from Thrombolytic Therapy of MI Estimates the risk of intracranial hemorrhage associated with thrombolytic therapy among MI patients Score
Acute Rheumatic Fever Jones Criteria for Acute Rheumatic Fever Diagnosis Diagnoses acute rheumatic fever based on major and minor criteria Criteria
Kawasaki Disease Kawasaki Disease Diagnostic Criteria Diagnoses Kawasaki Disease Criteria
Heart failure Killip Classification for Heart Failure Quantifies severity of heart failure in ACS and predicts 30-day mortality Classification
Readmission/Mortality LACE Index for Readmission Predicts 30-day readmission or death in patients on medicine and surgery wards Score
Heart failure/Mortality MAGGIC Risk for Heart Failure Estimates 1- and 3- year mortality in heart failure Score
Metabolic syndrome Metabolic Syndrome Criteria (AHA/NHLBI 2005) Assists to diagnose and manage metabolic syndrome Criteria
Metabolic syndrome Metabolic Syndrome Criteria (ATP III) Diagnoses of metabolic syndrome Criteria
Dyspnea mMRC (Modified Medical Research Council) Dyspnea Scale Stratifies severity of dyspnea in respiratory diseases, particularly COPD Classification
Mortality Modified Early Warning Score (MEWS) for Clinical Deterioration Determines the degree of illness of a patient Score
Chest pain Newsom Score for Non-traumatic Chest Pain Rules out need for chest x-ray in chest pain patients (non-traumatic) Criteria
Pacer Pacer Need After Heart Valve Surgery Predicts the need for permanent pacing after cardiac valve surgery Score
Pediatric Early Warning Score (PEWS) Identifies pediatric patients at risk for clinical deterioration Score
PE PERC Rule for Pulmonary Embolism Rules out PE if no criteria are present and pre-test probability is ≤15% Criteria
Operation PTCA Mortality Prediction Predicts the risk of major in-hospital complications following percutaneous coronary interventions Score
Pulmonary arterial hypertension REVEAL Registry Risk Score for Pulmonary Arterial Hypertension (PAH) Predicts survival in patients with pulmonary arterial hypertension Score
Stroke Risk of Paradoxical Embolism (RoPE) Score Identifies stroke-related PFO in patients with cryptogenic stroke Score
Imaging Romhilt-Estes Criteria for Left Ventricular Hypertrophy Electrocardiographic criteria for the diagnosis of left ventricular hypertrophy Score
Syncope San Francisco Syncope Rule Defines high-risk criteria for patients with syncope Criteria
Coronary artery disease Sgarbossa's criteria Assists to diagnose acute MI in patients with LBBB Criteria
Imaging Stress Test Outcome Risk Factors Predicts outcome in a community-based population undergoing stress testing Score
Stroke tPA Contraindications for Ischemic Stroke Provides inclusion/exclusion criteria when deciding to use tPA on a patient with acute ischemic stroke Criteria
Coronary artery disease Troponin-only Manchester Acute Coronary Syndromes (T-MACS) Decision Aid Rules out acute coronary syndrome Criteria
Coronary artery disease Unstable Angina and Tirofiban Benefit Prediction Predicts adverse outcomes and magnitude of benefit with glycoprotein IIb/IIIa inhibitor therapy in patients with unstable angina pectoris Score
Coronary artery disease Unstable Angina Risk Stratification (Piombo) Predicts stratify risk in unstable angina Score
Coronary artery disease Unstable Angina Risk Stratification (Solomon) Identifies patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy Score

CRITICAL CARE

Topic Calculators Purpose
Stroke Cincinnati stroke scale
Sepsis SIRS, Sepsis, and Septic Shock Criteria
Sepsis qSOFA (Quick SOFA) Score for Sepsis
Mortality Modified Early Warning Score (MEWS) for Clinical Deterioration Determines the degree of illness of a patient.

GASTROENTEROLOGY

Topic Calculators Purpose
Liver disease MELD Score
Liver disease Child-Pugh score for cirrhosis mortality
Pancreatitis Ranson criteria
Pericarditis Tygerberg score

HEMATOLOGY/ONCOLOGY

Topic Calculators Purpose
Myelofibrosis DIPSS Plus Score
CBC Absolute Neutrophil Count (ANC)

INFECTIOUS DISEASE

Topic Calculators Purpose
ENT Centor Score (Modified/McIsaac) for Strep Pharyngitis
Infective endocarditis/Mortality Infective Endocarditis (IE) Mortality Risk Score Predicts mortality at 6 months in patients with infective endocarditis.

NEPHROLOGY

Topic Calculators Purpose
Creatinine clearance
Sodium correction for hyperglycemia
Fractional Excretion of Sodium (FENa)
Calcium correction for hypoalbuminemia
Fluid Maintenance fluids calculations
Nephropathy Mehran Score for Post-PCI Contrast Nephropathy Predicts risk of contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI).
Electrolytes Calcium Correction for Hypoalbuminemia Calculates a corrected calcium level for patients with hypoalbuminemia.
Fluid Maintenance Fluids Calculations Calculates maintenance fluid requirements by weight.
Renal Artery Stenosis PTCA Mortality Prediction A Clinical Prediction Rule for Renal Artery Stenosis
Fluid Urine Output and Fluid Balance Calculates urine output over a 24-hour period.

NEUROLOGY

Topic Calculators Purpose
Level of consciousness Glasgow coma scale
Level of consciousness Pediatric Glasgow Coma Scale
Stroke Cincinnati stroke scale
Stroke NIH Stroke Scale/Score (NIHSS)
Arrythmia/Stroke Atrial Fibrillation Five Year Risk of Stroke (Framingham Heart Study) Predicts 5-year risk of stroke in patients with atrial fibrillation
Arrythmia/Stroke Atrial Fibrillation Five Year Risk of Stroke or Death (Framingham Heart Study) Predicts 5-year risk of stroke or death in patients with atrial fibrillation
Stroke/Mortality SOAR Score for Stroke, modified Predicts short-term mortality in acute ischemic stroke.
Bleeding Intracranial Bleeding Risk from Thrombolytic Therapy of MI Estimates the risk of intracranial hemorrhage associated with thrombolytic therapy among MI patients

PEDIATRICS

Topic Calculators Purpose
Level of consciousness Pediatric Glasgow Coma Scale
Neonatology Apgar score
Pediatric Early Warning Score (PEWS) Identifies pediatric patients at risk for clinical deterioration.

PULMONOLOGY

Topic Calculators Purpose
Pneumonia CURB-65
Pneumonia Pneumonia severity index
Pulmonary Vascular Resistance Calculates the pulmonary vascular resistance

ORTHOPEDICS

Topic Calculators Purpose
Open Fractures Mangled Extremity Score Clinician completed the score to determine which mangled limbs will eventually come to amputation.
Open Fractures Ganga Hospital Open Injury Score (GHOIS) Clinician completed the score to help them in decision making regarding salvage in IIIB injuries.
Knee (Anterior Cruciate Ligament) Modified Cincinnati Rating system Clinician and patient completed the score for evaluation of functional activity levels after surgery.
Knee (Anterior Cruciate Ligament) Tegner Lysholm Knee Scoring Scale Clinician and patient completed score for evaluation of functional activity levels after surgery.
Knee (Anterior Cruciate Ligament) KOOS (Knee Injury & Osteoarthritis Outcome) Patient completed the score to assess response to surgery and physical therapy for patients undergoing anterior cruciate ligament reconstruction.
Knee (Osteoarthritis) Oxford Knee Score Patient completed score to assess the severity of disability from osteoarthritis before and after 6 months of surgery.
Knee (Osteoarthritis) KOOS (Knee Injury & Osteoarthritis Outcome) Patient completed the score to assess severity in patients with osteoarthritis.
Knee (Osteoarthritis) WOMAC Score Patient completed the score for measuring quality of life (QOL) in patient suffering from osteoarthritis.
Knee (Osteoarthritis) IKDC Patient completed the score for evaluation of functional activity levels.
Knee (Osteoarthritis) Knee Society Score (KSS) Clinician completed score to assess objective knee disability, patient satisfaction and expectation level, and functional activity level.
Foot/Ankle American Foot & Ankle Score Clinician completed the score to provide a standard method of reporting clinical status of the ankle and foot.
Foot/Ankle Foot & Ankle Disability Index Patient completed the score for to assess functional limitations related to foot and ankle conditions.
Wrist MAYO Wrist Score Clinician completed the score to assess the outcome folowign management of scaphoid fractures.
Wrist DASH (Disabilities of arm, shoulder & hand) Score Patient completed the score to measure physical function and symptoms in patients with musculoskeletal disorders of the upper limb.
Wrist Quick-DASH Score Patient completed score to determine the disability experienced by patients with any musculoskeletal condition of the upper extremity and to monitor change in symptoms and upper limb function over time. It is a shortened version of the DASH.
Hand Michigan Hand Outcomes Questionnaire Patient completed the score which allowed assessment of activity of daily living in patients with hand disability.
Hand DASH (Disabilities of arm, shoulder & hand) Score Patient completed the score to measure physical function and symptoms in patients with musculoskeletal disorders of the upper limb.
Hand Quick-DASH Score Patient completed score to determine the disability experienced by patients with any musculoskeletal condition of the upper extremity and to monitor change in symptoms and upper limb function over time. It is a shortened version of the DASH.
Lumbar Spine Oswestry Low Back Pain Score Patient completed the score to determine the disability experienced by patients with low back pain.
Lumbar Spine Modified Oswestry Low Back Pain Score Patient completed score to determine the disability experienced by patients with low back pain before and after the surgery.
Lumbar Spine Back Pain Index Patient completed the score to determine how back condition affects their everyday life.
Cervical Spine Vernon & Mior Cervical Spine Score Patient completed score to how their neck pain has affected their ability to manage in everyday life.
Hip Harris Hip Score Clinician completed score for the assessment of the results of hip surgery, and is intended to evaluate various hip disabilities and methods of treatment in an adult population.
Hip Oxford Hip Score Patient completed score for to assess outcome after total hip replacement (THR) by measuring patients' perceptions in adjunction to surgery.
Hip HOOS (Hip disability and Osteoarthritis Outcome) Patient completed the score to give their opinion about their hip and associated problems, and is intended to be used in an adult population with hip disability with or without osteoarthritis.
Hip WOMAC Score Patient completed score for for measuring quality of life (QOL) in patient suffering from osteoarthritis.
Shoulder Constant Shoulder Score Clinician completed the score for clinical functional assessment for shoulder complaints before and after surgery.
Shoulder UCLA Shoulder rating scale Clinician completed the score to assess diability, pain and patient satisfaction.
Shoulder Oxford Shoulder Score Patient completed the score for assessment of pain and function of the shoulder.
Shoulder American Shoulder And Elbow Surgeons (ASES) Society Score Patient completed the score for assessing activities of daily living (ADL).
Shoulder DASH (Disabilities of arm, shoulder & hand) Score Patient completed the score to measure physical function and symptoms in patients with musculoskeletal disorders of the upper limb.
Shoulder Quick-DASH Score Patient completed score to determine the disability experienced by patients with any musculoskeletal condition of the upper extremity and to monitor change in symptoms and upper limb function over time. It is a shortened version of the DASH.
Shoulder (Instability) Rowe Score for Instability Clinician completed the score for assessing stability, motion and function after the surgery for shoulder instability.
Shoulder (Instability) Oxford Shoulder Instability Score Patient completed score for assessing the outcome of treatment for shoulder instability.
Shoulder (Instability) WOSI (Western Ontario Shoulder Instability Index) Patient completed the score for measuring disease-specific quality of life in patient suffering from shoulder instability.
Elbow MAYO Elbow Score Clinician completed the score for evaluating disability associated with elbow injuries.
Elbow Oxford Elbow Score Patient completed score to measures injury-related quality of life in patients following surgery of the elbow joint
Elbow DASH (Disabilities of arm, shoulder & hand) Score Patient completed the score to measure physical function and symptoms in patients with musculoskeletal disorders of the upper limb.
Elbow Quick-DASH Score Patient completed score to determine the disability experienced by patients with any musculoskeletal condition of the upper extremity and to monitor change in symptoms and upper limb function over time. It is a shortened version of the DASH.
VAS VAS Score Clinician and patient completed the score for evaluation of pain severity and relief.
Psychological DRAM (Distress and Risk Assessment Method) Patient completed the score to measure psychological distress in patients presenting for orthopaedic care.

SURGERY

Topic Calculators Purpose
MACE Cardiac Risk Index for AAA Surgery (Lee) Calculates the approximate risk of cardiac complication after AAA surgery
MACE Cardiac Risk Index for Abdominal Surgery (Lee) Calculates the approximate risk of cardiac complication after abdominal surgery
MACE Cardiac Risk Index for Pre-Operative Risk, revised Estimates risk of cardiac complications after noncardiac surgery.
Anesthesia Cardiac Anesthesia Risk Evaluation Score (CARE) Predicts mortality and morbidity after cardiac surgery.
MACE EuroSCORE for Cardiac Surgery Risk Assessment Estimates the mortality among cardiac surgical adult patients
Pacer Pacer Need After Heart Valve Surgery Predicts the need for permanent pacing after cardiac valve surgery
Operation PTCA Mortality Prediction Predicts the risk of major in-hospital complications following percutaneous coronary interventions
Cradiac surgery ACEF II Risk Score for Cardiac Surgery Predicts 30-day mortality after elective or emergency cardiac surgery.
Operation Postoperative Cardiac Risk Prediction calculates the prediction of cardiac risk after surgery